Edenwell Therapeutics Private Limited - Company Profile

It is a pharma private limited company based in Thane, Maharashtra, India, established in 2017.
2017 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Edenwell Therapeutics Private Limited

Edenwell Therapeutics Private Limited, a active private limited company, was established on 19 June 2017 in Thane, Maharashtra, India. Engaging in pharma contract r&d within the hospital and medical care sector, it holds CIN: U85320MH2017PTC296318. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.15 M.

It upholds a compliant status. Its leadership includes Parvez Ahmed Abdulgaffar Kosgi (Director), Shoeb Mohammed Kosgi (Director). Past directors included Kamlesh Bajirao Londhe, Shoeb Mohammed Kosgi. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 2003, W-26, Casa Celeste-L, Lodha Amara, Clariant Compound, Kolshet Road, Thane W, Est,, Thane, Maharashtra, 400607.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U85320MH2017PTC296318

  • Registration Number

    296318

  • Incorporation Date

    19 June 2017

  • Authorized Capital

    ₹0.50 M

  • Paid-Up Capital

    ₹0.15 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.15 M
  • Company Age 8 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 177.22%
  • Profit Growth **** 238.89%
  • Ebitda **** 385.48%
  • Net Worth 107.62%
  • Total Assets **** 43.85%
Company report

Edenwell Therapeutics Private Limited

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Edenwell Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Edenwell Therapeutics Private Limited?
Current Directors
Name Designation Appointment Date Status
Parvez Ahmed Abdulgaffar Kosgi Director 19 Jun 2017 Current
Shoeb Mohammed Kosgi Director 21 Nov 2018 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 23 Feb 2025 Past
Pramod Abcsdd Additional Director 30 Sep 2019 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Edenwell Therapeutics.

Edenwell Therapeutics Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 177.22% increase. The company also saw a substantial improvement in profitability, with a 238.89% increase in profit. The company's net worth Soared by an impressive increase of 107.62%.

Edenwell Therapeutics revenue growth over time
Edenwell Therapeutics profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 177.22%
*******
*******
*******
*******
Revenue from Operations
*******
 176.81%
*******
*******
*******
*******
Total Assets
*******
 43.85%
*******
*******
*******
*******
Profit or Loss
*******
 238.89%
*******
*******
*******
*******
Net Worth
*******
 107.62%
*******
*******
*******
*******
EBITDA
*******
 385.48%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Edenwell Therapeutics?

In 2020, Edenwell Therapeutics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Edenwell Therapeutics?

Unlock and access historical data on people associated with Edenwell Therapeutics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Edenwell Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Edenwell Therapeutics's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Edenwell Therapeutics
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Edenwell Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.

  • Balance Sheet

    Edenwell Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    Shoeb Mohammed Kosgi was appointed as a Director was appointed as a Director on 21 Nov 2018 & has been associated with this company since 7 years 6 months . was recorded as a recent event.

  • Director Appointment

    Parvez Ahmed Abdulgaffar Kosgi was appointed as a Director was appointed as a Director on 19 Jun 2017 & has been associated with this company since 8 years 11 months . was recorded as a recent event.

  • Company Incorporation

    The activity Edenwell Therapeutics Private Limited was registered on 19 Jun 2017 with Roc Mumbai & aged 8 years 11 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Edenwell Therapeutics Private Limited?

The CIN of Edenwell Therapeutics Private Limited is U85320MH2017PTC296318.

Where is Edenwell Therapeutics Private Limited headquartered?

Edenwell Therapeutics Private Limited is headquartered at 2003, W-26, Casa Celeste-L, Lodha Amara, Clariant Compound, Kolshet Road, Thane W, Est,, Thane, Maharashtra, 400607.

When was Edenwell Therapeutics Private Limited incorporated?

Edenwell Therapeutics Private Limited was incorporated on 19 June 2017.

Who are the current directors of Edenwell Therapeutics Private Limited?

The current directors of Edenwell Therapeutics Private Limited are

What is the primary industry of Edenwell Therapeutics Private Limited?

The primary industry of Edenwell Therapeutics Private Limited is Hospital And Medical Care.

Is Edenwell Therapeutics Private Limited a listed company?

Edenwell Therapeutics Private Limited is unlisted.

What is the capital structure of Edenwell Therapeutics Private Limited?

The authorized capital of Edenwell Therapeutics Private Limited is ₹0.50 M, and the paid-up capital is ₹0.15 M.

What is the compliance status of Edenwell Therapeutics Private Limited?

The compliance status of Edenwell Therapeutics Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available